CONTENTS:
- Over a decade later and Addiction journal is still committed to publishing qualitative research [Editorial]. Neale J., Kelly B.C., Braciszewski J.M., Kesten J., Lankenau S., Mayock P., et al., p. 1292-1294.
- Positive psychological interventions for substance use, addiction and recovery: An updated systematic review and meta-analysis. Carlon H.A., Hurlocker M.C., Hoeppner B.B., Witkiewitz K., p. 1295-1324.
- Commentary on Carlon et al.: High hopes - Integrating positive psychological interventions into substance use disorder treatment. Carrico A.W., p. 1325-1326.
- The impacts of e-cigarette flavours: An overview of systematic reviews. Livingstone-Banks J., Travis N., Conde M., Chen Y.C., Zi P., Jarman H., et al., p. 1327-1344.
- Lisdexamfetamine in the treatment of methamphetamine dependence: A randomised, placebo-controlled trial. Ezard N., Clifford B., Siefried K.J., Ali R., Dunlop A., McKetin R., et al., p. 1345-1359.
- Commentary on Ezard et al.: Prescribed psychostimulant medications for methamphetamine use disorder - an urgent path forward. Bisaga A., p. 1360-1362.
- Commentary on Ezard et al.: Agonist-based medications for stimulant use disorder-Distinguishing their true colours. Tardelli V.S., Fidalgo T.M., p. 1363-1365.
- The world's first anabolic-androgenic steroid testing trial: A two-phase pilot combining chemical analysis, results dissemination and community feedback. Piatkowski T., Coomber R., Francis C., Kill E., Davey G., Cresswell S., et al., p. 1366-1377.
- Commentary on Piatkowski et al.: Anabolic-androgenic steroid testing sites are necessary to identify specific anabolic-androgenic steroid types that are commonly faked putting users at risk. O'Connor T., p. 1378.
- Do the differing vaping and smoking trends in Australia and New Zealand reflect different regulatory policies? Mendelsohn C.P., Beaglehole R., Borland R., Hall W., Wodak A., Youdan B., et al., p. 1379-1389.
- Personalized chat-based support for smoking cessation among smokers with mental health symptoms in the workplace: A randomized controlled trial. Yao Y., Luk T.T., Lau O.S., Wu Y.S., Weng X., Ng C.H., et al., p. 1390-1401.
- Deficits in general and smoking-specific response inhibition in the Go/No-Go task in individuals who smoke: A cross-sectional analysis. Motka F., Kühn S., Wittekind C.E., p. 1402-1412.
- Do internalising or externalising behaviours in adolescence mediate the child maltreatment-alcohol substance use relationship? Trott M., Bull C., Najman J.M., Siskind D., Arnautovska U., Kisely S., p. 1413-1421.
- Relapse in substance-induced psychosis and associated risk factors. A Nationwide register-linkage study from Sweden. Ellilä V., Taipale H., Tiihonen J., Mittendorfer-Rutz E., Niemelä S., p. 1422-1430.
- Diagnostic validity of drinking behaviour for identifying alcohol use disorder: Findings from a representative sample of community adults and an inpatient clinical sample. Garber M.L., Samokhvalov A., Chorny Y., LaBelle O., Rush B., Costello J., et al., p. 1431-1440.
- Identifying hazardous alcohol use in primary care using phosphatidylethanol: Timing of screening matters. Mansson V., Hardstedt M., Hammarberg A., Hake A., LoMartire R., p. 1441-1449.
- Validation of the alcohol, smoking and substance involvement screening test (ASSIST) for identifying methamphetamine use among people on methadone maintenance treatment in Vietnam. Thai T.T., Nguyen D.B., Nguyen T.T., Hoang H.T., Li M., Li L., et al., p. 1450-1459.
- High BMI is a specific risk factor for drug-related mortality in patients receiving methadone: A case control study. Algahtani T., Le Ruez T., Strang J., Morgan D., Smith M., Copeland C.S., p. 1460-1465.
- National profile on substance use, substance use-related problems and policy: The case of Chile. Castillo-Carniglia A., p. 1466-1474.
- Did the United States smokeless tobacco industry use cigarette industry strategies to sponsor and manipulate research? Timberlake D.S., Nguyen B.D., Nguyen A.T., p. 1475-1483.
- Addiction Lives: Shekhar Saxena. Berridge V., p. 1484-1485.
- Deaths of despair. MacGregor S., Duke K., O'Gorman A., p. 1486-1487.
- Non-alcoholic beer labeling in the United States. Bowdring M.A., Prochaska J.J., p. 1488-1489.